SORT BY Relevancy
What are the latest developments in the world of GMOs? From GMO labeling laws, global outrage, corporate product pipelines, to the debacle over the Seralini study on human health risks, we will examine new aspects to the biotech business and their implications for the health and safety of consumers worldwide. We may know where we have been and we may know where we are in the midst of the genetically modified debate, but can we see where we are going?
The CMO of a biotech is like no other job in the world. The CMO is not only responsible for delivering on clinical trials, but also is a key player in the company's fundraising efforts.
From the Chief Medical Officer Summit, please join co-chairs Dr. Greg Fiore, CMO of the The Medicines Company and Dr. Steven Zelenkofske, CMO of Regado together with opening presenter Dr. Tyler Martin, CMO & Founder of Great Plains Biotechnology, to discuss the role of the CMO and how to best manage it.
What should a CMO be focused on? Functioning with restrictive capital Supporting a CEO who does not have experience in the therapeutic area you are in charge of The great balancing act
Martin & Company is a home based business providing all types of real estate appraisal services. Located in Durham, NC. The Research Triangle Park is one of the leading research and manufacturing areas for high tech, biotech, and medical research in America.
Jarvis Martin, founded Martin & Company in 1975. Mr. Martin joined the Society of Real Estate Appraisers as an associate member in 1977 and obtained his (SRA) Senior Residential Appraiser designation in 1982. Mr. Martin was selected by the NC State Appraisal License Board to take the initial North Carolina License exam and provided feedback to the state board. As a result of this experience Mr. Martin was one of the first 50 appraisers to be license in the State of North Carolina.
Mr. Martin operates his business with the assistance of his wife of 25 years, Norma B. Martin. Norma is a state license residential appraiser. The firm covers Durham, Wake, and Orange Counties in central North Carolina, providing appraisal services for most major lenders, local and state governmental agencies.
The use of Appraisal Port has enabled Martin & Company to better receive, track and deliver appraisal reports. The appraisers who are successful and profitable must be educated and equipped with the best, and latest technology to meet this demand.
The appraiser of today and the future must be able to provide a client with more than a form appraisal report. He/she must understand the “highest and best use” concept and be able to provide land use, income, and cost analysis.
Martin & Company - Real Estate Appraisers P.O. Box 1410 3608 Mossdale Ave. Durham, NC 27702
Phone: 9196825506 Fax: 9194931304 E-mail: firstname.lastname@example.org
The Total Tutor Neil Haley will interview David Hall.
David Hall – CEO, President & Director
For more than a decade, Mr. Hall held executive management roles at Angiotech Pharmaceuticals Inc. including Chief Financial Officer, Chief Compliance Officer and Senior Vice President of Government & Community Relations. He also served as the company’s Corporate Secretary and Treasurer. Mr. Hall is highly committed to governmental policy issues related to the biotech industry. He is a past Chairman and current board member of Life Sciences BC and currently serves as a director of Advantage BC. He has served as the Chairman of the Biotech Industry Advisory Committee to the BC Competition Council and as a member of the BC Task Force on PharmaCare. Mr. Hall is also a member of the University of British Columbia’s Tech Equity Investment Committee and is a director and Chairman of the Audit Committee of GLG Lifetech Corporation.
It is still a fairly new-recognized and rapidly increasing reality. Gluten intolerance has become a primary health concern for millions of consumers around the world. However, in the face of such an epidemic, the biotech industry is in aggressive pursuit of genetically manipulating a relief for this affliction, one they seek undoubtedly to capitalize on. If brought to fruition, the result of such a genetically engineered response may in actuality cause more grave consequences to consumers than it will provide them help. Revealing the latest research and what it says about gluten intolerance and the dangers involved with GM alternatives currently under development. If you are one of the millions suffering from this affliction, please don't miss out on hearing the important information brought to you in this broadcast.
Linda Peacock is currently an Infusion Account Manager for a global biotech company. Linda’s role is educating healthcare professionals in hospitals, infusion centers, and offices in a large territory in the Northeast.
An accomplished health management professional with extensive clinical expertise within the hospital, specialty pharmacy, pharmaceutical and biotech industries, Linda's career spans several decades and includes 17 years at Albany Medical College and nine years as an Assistant Executive Director of a regional hemophilia center. She has been very successful in many roles in the pharmaceutical industry, including with her current company.
Linda received her RN in 1992 after many years as a nurse’s aide and LPN. In 1994, she received her BSN at Regents College (now known as Excelsior College). In 1999, she was awarded an MBA by the State University New York at Albany.
Joining Host Kelly Scanlon on Smart Companies KC this week, the President and founder, Lisa A. Stehno-Bittel and Vice President and founder Karthik Ramachandran, Ph.D of Likarda, LLC,
Eentrepreneurs disguised as scientists at the University of Kansas, launched Likarda as an exciting biotech company bringing to market disruptive technologies that improve healthcare outcomes and lower costs for pets and people alike. As the leading regenerative medicine company for companion animals, Likarda has discovered — and is commercializing — a new dimension for managing diabetes in dogs and cats. Likarda LLC is one of the 25 Under 25® Class of 2015 honorees in Kansas City.
To hear more shows with Host Kelly Scanlon please visit our Smart Companies KC archives
Wednesday, February 11, 2015
(2-4pm Mountain; 3-5pm Central, 4-6pm Eastern)
This week on One Cell One Light Radio, Dr. Hildy discusses the phenomenon behind “winged cats” - cats with wing-like appendages. But the unusual animal investigation doesn’t stop there. Also discussed will be the Ayam Cemani chicken of Indonesia, a rare breed whose entire body is black. Not just feathers, but head, beak, eyes, legs and even the insides.
Oxitec, a British biotech company, plans to release an experimental mosquito population in the Florida Keys genetically engineered to combat dengue fever. Local residents are concerned for a number of reasons, such as the lack of testing done, and the sudden introduction of a non-native species into the local population.
Are mosquitoes just the tip of the iceberg? According to some accounts, genetically modified “micro humans” could be used in scientific testing within two years. Although the dangers of genetically engineered humans should be obvious, the benefits could outweigh the cost if there is the possibility of eradicating diseases and potentially find a cure for the greatest disease of all: aging and death.
MUCH MORE >>>
In September 2012, TransCelerate Biopharma launched with the aim of simplifying and accelerating the delivery of innovative medicines to patients. What progress has really been made and what are the realistic goals for 2015? In our 2015 kick off radio show, Clinical Air Episode #13, host Craig Lipset, Head of Clinical Innovation, R&D, Pfizer talks with Dalvir Gill, PhD, CEO of Transcelerate and Andy Lee, MD, SVP, Head of Global Clinical Trial Operations at Merck. In this frank discussion, we learn:
What’s working well and changes for 2015?
Is Tanscelerate performing better or differently from other collaborations?
How have engagements with outside organizations advanced? Where do gaps remain?
How are new areas selected and scope defined?
Thoughts on implementing new ideas
New role for CROs
What deliverables does Tanscelerate anticipate for 2015?
Could an experience in a past life be impacting your life today? Clairvoyant Energy Healer Dr. Lesley Philips returns to the show to explore past lives and help you overcome a past trauma or unresolved issue so you can move forward in your current life experience. Dr. Lesley will help you understand where you are in your Spiritual Growth Cycle and how a past life experience is assisting you in deepening your compassion and understanding for your current circumstances. Learn to detach the threads to past life emotional patterns to create a positive, harmonious present.
To access the archives of all of Dr. Lesley’s appearances, visit www.SpiritualInsightsRadio.com.
Dr. Lesley is trained as a Biotech Research Scientist but is also a Clairvoyant, Spiritual Teacher and Counselor, Meditation Teacher and Energy Healer who empowers others to take charge of their lives by teaching them to develop their intuition, healing and creativity. She is the author of The Midas Tree, a novel similar to the magical style of Harry Potter. Makes a great gift!
Dr. Lesley does a variety of Readings including Medical Intuitive Sessions. Visit her website to book a Reading or Mentoring Session (via by Skype or phone) and for inspiring products and Training and Mentoring Programs for all ages. Dr. Lesley also holds private and corporate meditation workshops.
Also, all Subscribers to her site get 5 Special Free Gifts and a free 1 card reading (ask your question; the answer with the card will be e-mailed to you.)
To celebrate the airing of our 25th broadcast episode, tonight's show examines some of the highlights in previous shows and developments that have happened since. A discussion about everything from GMO labeling, to the global presence of agribusiness, to the frightening innovations under design in the biotech industry that may have serious impacts on consumers before another year comes to pass. We have seen good progress in consumer awareness and global action for change over the course of our previous broadcasts since first airing in January, 2013. But how much further do we have to go? Have we reached the point of no return? With planetary impact, climate change, and consumer health in the balance, find out how the link to GMO is affecting us all.
Leading with Intention: Every Moment Is a Choice by Mindy Hall, PhD
This on demand audio series is a part of the Executive Girlfriends Group Vignette Series. Chicke Fitzgerald interviews Mindy Hall. The original live interview was 12/12/14.
Leading with Intention challenges you to make a profound, deliberate mark on both your organization and the world around you. Informed by over 25 years of experience with leaders in Fortune 50 companies, biotech start-ups, financial services firms, and non-profit organizations, Leading with Intention provides real-life examples and practical tools for increasing your awareness and being more deliberate in your choices.
Mindy Hall, PhD is the President and CEO of Peak Development Consulting, LLC. Mindy has over 25 years of experience in organization and leadership development.
Mindy's website is peakdevelopment.com/
To order the book click HERE
For more information about the Executive Girlfriends' Group see: http://www.executivegirlfriendsgroup.com